Canopy Growth Launches Initial American CBD Products – New Cannabis Ventures

Canopy Growth Introduces First & Free – A Line of Branded Hemp-Derived CBD Products to the U.S. Market

Canopy Growth’s first line of CBD products are available for purchase through e-commerce platform available at

DENVER, Dec. 12, 2019 /PRNewswire/ – Canopy Growth Corporation, USA, LLC (TSX: WEED) (NYSE: CGC) (“Canopy Growth” or the “Company”) today announced the launch of First & Free – a hemp-derived CBD product line offered in a variety of formats, including softgels, oil drops and creams. The products will be available for purchase on the company’s first e-commerce site:

Perfected through state-of-the-art technology and rigorous testing, First & Free products are created by extracting and isolating derivatives from the hemp plant to produce pure and consistent CBD formulations that are packaged in easy-to-use formats.

First & Free marks a new way for US consumers to purchase quality CBD products from a trusted source.

Rade Kovacevic, President, Canopy Growth

Through state-of-the art extraction methods, strict quality control measures, and scientific research, we are delivering a best-in-class product to the market.

At launch, the First & Free brand will offer the following hemp-derived CBD products:

  • First & Free Oil Drops
    • Unflavored 25 mg per mL (750 mg per 30 mL bottle)
    • Peppermint flavor 25 mg per mL (750 mg per 30 mL bottle)
  • First & Free Softgels
    • 250 mg CBD carton (10 softgels)
    • 750 mg CBD  bottle (30 softgels)
    • 1500 mg CBD bottle (30 softgels)
  • First & Free Creams*
    • 2500 mg Everyday Cream (CBD Only)
    • 2500 mg Motion Cream (CBD + Arnica)
    • 2500 mg Revitalize Cream (CBD + Capsaicin)

Canopy Growth is committed to selling only high-quality, tested and reliable products, and ensuring it makes no claims unless clinically validated. This means selling First & Free products only in states where permissible under state law in order to ensure compliance with state consumer protection mandates and following the most stringent state laws regarding sale of CBD. The Company is also abiding by existing FDA regulations for manufacturing, labeling and marketing dietary supplements.

For more information, please visit

Here’s to Future ( United States  made, First & Free CBD) Growth.

* Creams coming soon

About Canopy Growth Corporation

Canopy Growth (TSX:WEED,NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across five continents.

Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.

Canopy Growth operates retail stores across  Canada  under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and  Seth Rogen , breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 10.5 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit

Original press release

For fact-based information on Canopy Growth Corp, view the company’s sponsored Investor Dashboard.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter

Dodaj komentarz